This book presents an up to date ethical framework for radiological protection in medicine. It is consistent with the requirements of the system of radiation protection and with the expectations of medical ethics. It presents an approach rooted in the medical tradition, and alert to contemporary social expectations. It provides readers with a practical framework against which they can assess the safety and acceptability of medical procedures, including patients' concerns. It will be an invaluable reference for radiologists, radiation oncologists, regulators, medical physicists, technologists, other practitioners, as well as academics, researchers and students of radiation protection in medicine. Features: An authoritative and accessible guide, authored by a team who have contributed to defining the area internationally Includes numerous practical examples/clinical scenarios that illustrate the approach, presenting a pragmatic approach, rather than dwelling on philosophical theories Informed by the latest developments in the thinking of international organizations

In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Megan R. Haymart and Maria Papaleontiou bring their considerable expertise to the topic of Thyroidology. Top experts in the field cover recent advances in the diagnosis and management of thyroid conditions, providing a contemporary view of updates in this challenging field. Contains 12 relevant, practice-oriented topics including disparities in thyroid care; the use of LT4/LT3 combinations in treating hypothyroidism; minimally invasive procedures for thyroid nodules; less intensive management options for low-risk thyroid cancer; and more. Provides in-depth clinical reviews on thyroidology, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This classic text offers a comprehensive, yet concise and manageable overview of oncology nursing. This edition expands on the previous edition by pulling out the symptom management subjects into their own unit. Also includes over 400 multiple-choice review questions for each chapter case study to promote effective content review as well as OCN (R) and AOCN (R) certification preparation. Comprehensive yet concise overview of oncology nursing Consistent format in disease chapters for quick access and understanding of key information Review questions with answers and rationales at the end of each chapter New chapter on Functional Status and its effect on patient outcomes New chapter on Ethical Considerations for the oncology nurse New chapters on Skin Integrity, Oral Mucositis, Bone Marrow Suppression New chapter on Palliative Care offers information regarding providing physical and emotional comfort to dying patients and their families New chapters on Patient Education and Family Caregiving for information on assisting families that provide needed health services and support outside of the healthcare setting New Symptom Management unit with new chapters on Dyspnea, Sleep Disturbance, Nausea, and Hot Flashes Case studies at the end of each chapter correspond with chapter content and review questions with rationales

In this issue of Hematology/Oncology Clinics, guest editors Drs. Kimmie Ng and Benjamin L. Schlechter bring their considerable expertise to the topic of Colorectal Cancer. Despite tremendous progress in the management of this disease, many questions and controversies remain regarding screening, adjuvant therapy for resected colon cancers, targeted therapies and immunotherapy for patients with advanced disease, surgical management, and more. In this issue, top experts in the field address provide clinicians with the tools to individualize management and optimize care for this growing patient population. Contains 13 relevant, practice-oriented topics including screening for colorectal cancer; hereditary colorectal cancer; disparities in colorectal cancer; microbiome in colorectal cancer; impact of diet and exercise on colorectal cancer; colorectal cancer in younger adults; and more. Provides in-depth clinical reviews on colorectal cancer, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

An accessible and engaging review of board exam essentials Cardiology Board Review lays the groundwork for board exam success with its instructive and easy-to-read explanations of the pathophysiology, diagnosis, and treatment of patients with cardiovascular disease. Breaking topics down into case unknowns, this innovative revision aid provides examples of everyday cardiological issues and then explains how best to address the problem at hand. All content is complemented by clinical images and illustrations, as well as helpful summaries and key points. Featuring 56 different cases, this essential text: Places learning in a practical context. Information about disease states is presented in case-based format which leads to better retention. Covers topics including congenital heart disease, coronary artery disease, cardiomyopathies, valvular heart disease, arrhythmias, heart failure, peripheral vascular disease, and more Designed to present important concepts and information in a unique way to complement textbook learning Features electrocardiograms, angiograms, and pressure tracings Is applicable to those working towards certification in Cardiovascular Disease from the American Board of Internal Medicine or preparing for board examinations in other countries Is also suitable for those requiring MOC recertification Features cases on aortic insufficiency, atrial fibrillation, Brugada syndrome, carotid artery disease, myocardial bridging, congenital heart disease, electrolyte abnormalities, apical HCM, mitral regurgitation, RV outflow tract tachycardia, pulmonary hypertension, arrhythmogenic right ventricular dysplasia, aortic stenosis, atrial myxoma, atrial tachycardia, pulmonic insufficiency, Takotsubo, tricuspid regurgitation, Wolfe-Parkinson-White syndrome, pulmonic stenosis, coronary anomalies, ECG changes of hypothermia, endocarditis, pulmonary embolus, ventricular septal defect, hemodynamics of hypertrophic cardiomyopathy, complete heart block, heart failure, coronary artery disease, atrial septal defect, constrictive pericarditis, fractional flow reserve, dextrocardia, STEMI, early repolarization, giant cell myocarditis, peripheral arterial disease, pericardial tamponade, peripheral arterial disease, pericarditis, myocarditis, long QT syndrome, mitral stenosis, tetralogy of Fallot, and supraventricular tachycardia among others. Cardiology Board Review offers fellows a fresh and engaging approach to the information required to achieve success in board examinations.

Mesothelioma used to be a rare disease, but because of the widespread use of asbestos it has now been described as an epidemic around the world. The disease has proven exceptionally resistant to common forms of treatment (chemotherapy, radiotherapy and surgery). Mesothelioma has a very aggressive natural history with a median survival of around 9 months. There has been an explosion in knowledge about mesothelioma in the past few years, partly stimulated by the formation of the International Mesothelioma Interest Group network. This book represents a state-of-the-art review of the disease, from laboratory through to the bedside, from diagnostic procedures through to treatment and from imaging and early detection through to medico-legal aspects. It will be of interest to any clinician or scientist with any involvement in asbestos-related diseases, as well as members of the legal profession and anyone with an interest in respiratory diseases.

Now in its second edition, this is the only book on occupational therapy in oncology and palliative care. It has been thoroughly updated, contains new chapters, and like the first edition will appeal to a range of allied health professionals working with patients with a life-threatening illness.

The book explores the nature of cancer and challenges faced by occupational therapists in oncology and palliative care. It discusses the range of occupational therapy intervention in symptom control, anxiety management and relaxation, and the management of breathlessness and fatigue.

The book is produced in an evidence-based, practical, workbook format with case studies. New chapters on creativity as a psychodynamic approach; outcome measures in occupational therapy in oncology and palliative care; HIV-related cancers and palliative care.

This book provides up-to-date, clinically relevant information on a range of complex issues relating to supportive care strategies for the recipients of hematopoietic cell transplantation. The topics addressed include the prevention, recognition, and treatment of transplant-related side effects; management of pretransplant comorbidities; supportive care for specific age groups; quality of life issues in patients who experience graft-versus-host disease; mental and spiritual health care; caregiver and healthcare provider support strategies; and important issues related to end of life care. The aim is to supply hematologists, oncologists, transplant specialists, and palliative care physicians with practical knowledge that can be immediately applied in patient care to optimize transplant-related outcomes. The book's format, which offers concise, non-exhaustive coverage of these and other unique topics, is supplemented by a wealth of working tables, algorithms, and figures, ensuring that it will also serve hematology, oncology and transplant trainees as a reliable companion during their daily work. The authors are world-renowned experts in the field of hematopoietic transplantation and palliative care medicine, and present well-reasoned opinions based on their own experiences and draw attention to relevant results from potentially high-impact clinical trials.

This open access book summarizes the latest scientific findings regarding the biological effects of the Fukushima Daiichi Nuclear Power Plant (FNPP) accident in 2011. Various cases of changes in animals and organisms have been reported since the FNPP accident. However, it is often unknown whether they are actually due to radiation, since the dose or dose-rate are not necessarily associated with the changes observed. This book brings together the works of radiation biologists and ecologists to provide reliable radioecology data and gives insight into future radioprotection. The book examines the environmental pollution and radiation exposure, and contains valuable data from abandoned livestock in the ex-evacuation zone and from wild animals including invertebrates and vertebrates, aqueous and terrestrial animals, and plants that are subjected to long-term exposure in the area still affected by radiation. It also analyzes dose evaluation, and offers new perspectives gained from the accident, as well as an overview for future studies to promote radioprotection of humans and the ecosystem. Since the biological impact of radiation is influenced by various factors, it is difficult to scientifically define the effects of low-dose/low-dose-rate radiation. However, the detailed research data presented can be combined with the latest scientific and technological advances, such as artificial intelligence, to provide new insights in the future. This book is a unique and valuable resource for researchers, professionals and anyone interested in the impact of exposure to radiation or contamination with radioactive materials.

Increasing attention is being paid to the needs of cancer patients who present acutely with issues relating to their diagnosis an management, complications of their cancer, complications arising from their treatment, or who require appropriate symptom control or palliative care. Recent years have seen substantial service development to ensure acute oncology is appropriately provided, to improve outcomes and wellbeing of patients. A team of experts in cancer care have completely revised and updated the previous edition of this book to produce a template that can be used by any professional involved in the planning and delivery of acute oncology care around the world. This title is formally supported by the Association of Cancer Physicians (ACP). This highly patient-centred, readable text will be of value to clinicians and healthcare professionals, healthcare strategic and operations managers, and doctors in training, in their daily work.

Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology aims to describe links between cancer, precision oncology, and liquid biopsy, focusing on their participation to immunotherapy management. The book provides updated information on the main applications of liquid biopsy and immunotherapy as well as interesting aspects useful for planning basic and translational research activities. It helps readers understand the central aspects of precision medicine in oncology, including the use of new generation technologies for translational and diagnostic settings and the main clinical trials in this area that may be useful during their research. The book is a valuable source for cancer researchers, oncologists and other members of the medical and biomedical field who are interested in learning more about recent developments in liquid biopsy and its relationship with precision medicine and immunotherapy.

Helps researchers in proteomics and oncology work together to understand, prevent, and cure cancer

Proteomic data is increasingly important to understanding the origin and progression of cancer; however, most oncologic researchers who depend on proteomics for their studies do not collect the data themselves. As a result, there is a knowledge gap between scientists, who devise proteomic techniques and collect the data, and the oncologic researchers, who are expected to interpret and apply proteomic data. Bridging the gap between proteomics and oncology research, this book explains how proteomic technology can be used to address some of the most important questions in cancer research.

"Proteomic Applications in Cancer Detection and Discovery "enables readers to understand how proteomic data is acquired and analyzed and how it is interpreted. Author Timothy Veenstra has filled the book with examples--many based on his own firsthand research experience--that clearly demonstrate the application of proteomic technology in oncology research, including the discovery of novel biomarkers for different types of cancers.

The book begins with a brief introduction to systems biology, explaining why cancer is a systems biology disease. Next, it covers such topics as: Mass spectrometry in cancer researchApplication of proteomics to global phosphorylation analysisSearch for biomarkers in biofluidsRise and fall of proteomic patterns for cancer diagnosticsEmergence of protein arraysRole of proteomics in personalized medicine

The final chapter is dedicated to the future prospects of proteomics in cancer research.

By guiding readers through the latest proteomic technologies and their applications in cancer research, "Proteomic Applications in Cancer Detection and Discovery" enhances the ability of researchers in proteomics and researchers in oncology to collaborate in order to better understand cancer and develop strategies to prevent and treat it.

In this issue of Surgical Clinics, guest editor Dr. John M. Kane brings his considerable expertise to the topic of A Surgeon's Guide to Sarcomas and Other Soft Tissue Tumors. In 2021, more than 13,400 new soft tissue sarcomas will be diagnosed. This issue provides a timely update for management of the most common sarcomas, including discussions of pathology, imaging, chemotherapy, radiation, and reconstruction. Contains 13 relevant, practice-oriented topics including the implications of an unplanned sarcoma excision (the "Whoops" operation); the importance of preoperative pathology and the optimal biopsy of soft tissue masses; gastrointestinal stromal tumors (GIST) and the general surgeon; the evolving management of desmoid/aggressive fibromatosis; plastic surgery reconstruction of sarcoma resection defects; and more. Provides in-depth clinical reviews on sarcomas and other soft tissue tumors, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume Two: Diagnosis, Therapeutic Targets and Molecular Mechanisms for Hepatocellular Carcinoma Progression provides comprehensive information about ongoing research and clinical data surrounding liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. The volume discusses topics such as computational approaches for identification of biomarkers, enzymes and pathways of HCC, circulating and epigenetic biomarkers, drug resistance, metabolic pathways, and small molecule-target therapies. In addition, it discusses immunotherapies, immune check point inhibitors and nanotechnology-based therapies. This book is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.

Diary of a Detour is film scholar and author Lesley Stern's memoir of living with chronic lymphocytic leukemia. She chronicles the fears and daily experience of coming to grips with an incurable form of cancer by describing the dramas and delving into the science. Stern also nudges cancer off center stage by turning to alternative obsessions and pleasures. In seductive writing she describes her life in the garden and kitchen, the hospital and the library, and her travels-down the street to her meditation center, across the border to Mexico, and across the world to Australia. Her immediate world is inhabited with books, movies, politics, and medical reports that provoke essayistic reflections. As her environment is shared with friends, chickens, a cat called Elvis, mountain goats, whales, lions, and microbes the book opens onto a larger than human world. Intimate and meditative, engrossing and singular, Diary of a Detour offers new ideas about what it might mean to live and think with cancer, and with chronic illness more broadly.

This book comprehensively summarizes the adverse effects of tobacco smoking on human health. The current second edition has integrated a large set of new data that have been published in numerous scientifc studies and meta-analyses over the past few years. Unfortunately, the harmful sequelae of tobacco smoking are played down by the ind- try and politicians in many industrialized countries. However, about 800,000 people/year in the EU die from the immediate consequences of smoking. The particularly insidious feature of tobacco consumption is that smoking-attributable harmful effects on health do not generally become apparent until three or four decades after smoking initiation. Although some positive changes in the legislative handling of tobacco have appeared in the past fve years, we still need to form a pact, sealed by politicians, the medical prof- sionals, teachers and the media, to target the problem across nations. In this respect, a minority of countries, including the US and the UK, have given positive examples. There are four areas that need to be improved in future: (1) strict bans on tobacco adv- tisement on a global level, (2) better measures to protect against side-stream (passive) smoke exposure, (3) establishment of prevention programs, especially for children and (4) tre- ment of tobacco addiction.

Cutaneous T-cell lymphoma (CTCL) is a general term for many lymphomas of the skin including mycosis Fungoides and Sezary syndrome. This book presents the state of the art in CTCL epidemiology, clinical features, pathology, immunochemistry, diagnostic molecular techniques, staging and prognosis, and treatment. Edited by one of the leading experts in the disease, Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrome provides comprehensive coverage of the disease and presents techniques for diagnosis and state-of-the-art treatment modalities, such as ultraviolet light, steroids, and topical chemotherapeutics.

Why the War on Cancer Has Failed and What That Means for More Effective Prevention and Treatment A groundbreaking look at the role of water in living organisms that ultimately brings us closer to answering the riddle of the etiology of, and therapy and treatment for, cancer When President Nixon launched the War on Cancer with the signing of the National Cancer Act of 1971 and the allocation of billions of research dollars, it was amidst a flurry of promises that a cure was within reach. The research establishment was trumpeting the discovery of oncogenes, the genes that supposedly cause cancer. As soon as we identified them and treated cancer patients accordingly, cancer would become a thing of the past. Fifty years later it's clear that the War on Cancer has failed-despite what the cancer industry wants us to believe. New diagnoses have continued to climb; one in three people in the United States can now expect to battle cancer during their lifetime. For the majority of common cancers, the search for oncogenes has not changed the treatment: We're still treating with the same old triad of removing (surgery), burning out (radiation), or poisoning (chemotherapy). In Cancer and the New Biology of Water, Thomas Cowan, MD, argues that this failure was inevitable because the oncogene theory is incorrect-or at least incomplete-and based on a flawed concept of biology in which DNA controls our cellular function and therefore our health. Instead, Dr. Cowan tells us, the somatic mutations seen in cancer cells are the result of a cellular deterioration that has little to do with oncogenes, DNA, or even the nucleus. The root cause is metabolic dysfunction that deteriorates the structured water that forms the basis of cytoplasmic-and therefore, cellular-health. Despite mainstream medicine's failure to bring an end to suffering or deliver on its promises, it remains illegal for physicians to prescribe anything other than the "standard of care" for their cancer patients-no matter how dangerous and ineffective that standard may be-and despite the fact that gentler, more effective, and more promising treatments exist. While Dr. Cowan acknowledges that all of these treatments need more research, Cancer and the New Biology of Water is an impassioned plea from a long-time physician that these promising treatments merit our attention and research dollars and that patients have the right to information, options, and medical freedom in matters of their own life and death.

The Link between Obesity and Cancer provides a comprehensive review on the relationship between obesity and cancer, presenting global perspectives on obesity and cancer incidence that are followed by in-depth discussions on cancers for which we have new evidence of a causal relationship with obesity. Readers will gain fundamental knowledge on which cancer types are related to obesity. In addition, this updated resource provides significant knowledge for clinicians on when to act, along with specific management guidelines for patients, as well as how to understand potential risk factors and how to directly or indirectly minimize these risks. The book also provides never-before-published scientific data for any researcher in the field, identifying molecular mechanisms and links behind the development of malignancy and promoting research in new and effective target pathways in developing therapeutic strategies.

This open access book focuses on diagnostic and interventional imaging of the chest, breast, heart, and vessels. It consists of a remarkable collection of contributions authored by internationally respected experts, featuring the most recent diagnostic developments and technological advances with a highly didactical approach. The chapters are disease-oriented and cover all the relevant imaging modalities, including standard radiography, CT, nuclear medicine with PET, ultrasound and magnetic resonance imaging, as well as imaging-guided interventions. As such, it presents a comprehensive review of current knowledge on imaging of the heart and chest, as well as thoracic interventions and a selection of "hot topics". The book is intended for radiologists, however, it is also of interest to clinicians in oncology, cardiology, and pulmonology.

In this issue of Hematology/Oncology Clinics, guest editor Dr. Harold J. Burstein brings his considerable expertise to Breast Cancer. Top experts provide a comprehensive update on multidisciplinary management of early- and late-stage breast cancer, including key topics such as global perspectives on the epidemiology and treatment of breast cancer; breast cancer pathology in the era of genomics; optimizing radiation therapy after breast conserving surgery; and more. Contains 16 relevant, practice-oriented topics including disparities in breast cancer outcomes and how to resolve them; genetic testing in breast cancer; the role of ovarian suppression in early stage premenopausal breast cancer; multidisciplinary management of brain metastases from breast cancer; evidence-based guidance for breast cancer survivorship; and more. Provides in-depth clinical reviews on breast cancer, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

The Oxford Handbook of Palliative Care returns for a third edition, maintaining the concise yet comprehensive format suited to the busy practitioner for quick access to key information, and fully updated to reflect changes in the palliative care landscape. Featuring an increased emphasis on non-malignant diseases such as dementia, this authoritative text combines evidence-based care with the bedside experience of experienced palliative care professionals to give the reader a complete overview of the physical, emotional, and spiritual aspects of care for the end-of-life patient. Symptom management is covered in detail, with updated formulary tables and syringe driver protocols, and a new chapter on international perspectives to broaden the reader's perception of methods for delivering end-of-life care. The third edition of the Oxford Handbook of Palliative Care is the essential companion for all of those working with adults, children, and families with palliative care needs, in both hospital and community settings. The following correction has been made online and will be included in the first reprint. Readers can get in touch with us directly using the contact details on the back of the book or at our online form via the address below with questions or comments: https://global.oup.com/academic/category/medicine-and-health Chapter 5. Page 109 The dose for Hyoscine butylbromide sc has been amended in line with NICE guidance (https://bnf.nice.org.uk/drug/hyoscine-butylbromide.html): '20-120 mg 4 hourly' has been corrected to '20-80mg 4 hourly'.

Contents:
1. Thrombosis and Cancer: a Short History of Trousseau's Syndrome 2. Pathogenesis of Thrombosis in Cancer 3. Platelets and Cancer 4. The Role of Clotting Factors in Tumor Metastasis: a case for Tissue Factor 5. The Role of Fibrinolysis in Cancer 6. Tumor Angiogenesis and Blood Coagulation 7. Risk of Cancer in Patients Presenting with Venous Thromboembolism 8. Thrombotic Complications of Overt Cancer 9. Systemic Microangiopathies in the Cancer Patient 10. Thrombophilia and the Risk of Venous Thrombosis in Cancer Patients 11. Long-term Thrombotic Complications in Cancer Treated Patients: the Problem of Recurrent Venous Thromboembolism 12. Prevention of Cancer Associated Thrombosis: an Overview 13. Thromboprophylaxis in Cancer Surgery 14. Catheter Related Arm Vein Thrombosis in Patients with Cancer 15. Prevention and Treatment of Thrombosis in Cancer Patients 16. Antimalignant Properties of Antithrombotic Agents

The most comprehensive guide available on hereditary cancers, from understanding risk, prevention, and genetic counseling and testing to treatment, quality of life, and more. Up to 10 percent of cancers are caused by inherited mutations in specific genes. Finding out that you or your loved ones may be at increased risk of developing cancer because of a genetic mutation raises a lot of questions: Is cancer inevitable? Is there anything I should do differently in my life? Will my children also be at higher risk of cancer? Should I have preemptive treatments or surgery? This comprehensive guide provides answers to these questions and more. Written by three passionate patient advocates, this book is a compilation of the trusted information and support provided for more than two decades by Facing Our Risk of Cancer Empowered (FORCE), the de facto voice of the hereditary cancer community. Combining the latest scientific research with national guidelines, expert advice, and compelling patient stories, the book offers previvors (those who have a mutation but have never been diagnosed), survivors, and their families the guidance they need to face the unique physical and emotional challenges of living in a high-risk body. An ideal resource for genetic counselors, physicians, nurses, advocates, and others who support and care for the hereditary cancer community, Living with Hereditary Cancer Risk also provides coverage of * signs of inherited cancer risk in a family; * the value of genetic counseling and testing; * mutations in BRCA, Lynch Syndrome, and other genes that elevate cancer risk; * risk-reducing strategies; * traditional treatments and newer personalized approaches, including immunotherapies and PARP inhibitors; * nationally recommended guidelines for prevention, early detection, and treatment; * insurance coverage and discrimination protections; and * coping with sexual health, fertility, menopause, and other quality of life issues.

The first complete overview of progress in the field. The two volumes contain selected articles from the prestigious online Encyclopedia of Molecular Cell Biology and Molecular Medicine, fully updated and enriched with numerous new contributions from many eminent scientists. Divided into three parts, the first gives a thorough introduction to cancer biology, while Part Two covers therapeutic approaches for all major forms of cancer, and the third part deals with cancer diagnostics. The result is a one-stop resource for advanced students, postdoctoral researchers and start-up companies.